Skip to main content

Tag Drugs

Waisman Biomanufacturing partners with GigaGen to manufacture new COVID-19 drug

September 9, 2020

The drug, called GIGA-2050, uses a new approach similar to treating COVID-19 patients with convalescent plasma.

UW–Madison and UW Health selected as sites to test new COVID-19 vaccine

August 31, 2020

They are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent the disease.

Forecasting antibiotic resistance with a ‘weather map’ of local data

February 22, 2018

To help physicians choose the best antibiotic first, researchers in the School of Pharmacy and the State Cartographer's Office are drawing inspiration from the weather.

Undocumented immigration doesn’t worsen drug, alcohol problems in U.S., study indicates

July 31, 2017

An increase in the proportion of the population that is undocumented is associated with fewer drug arrests, drunken driving arrests and drug overdoses.

UW-Madison advisory board aids cancer treatment statewide

June 29, 2017

The Precision Medicine Molecular Tumor Board has a dual mission: consulting with oncologists statewide about targeted drugs to battle out-of-control cancers; and amassing data on what works and what does not.

Chemistry method expedites path to useful molecules for medicine

September 1, 2016

The new method gives chemists prospecting for bioactive molecules a new tool in the search for novel drugs or chemicals for agriculture.

Faster, smaller, cheaper: Technique could speed biologic drugs

April 20, 2015

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront of drug discovery. So drug companies want a faster route to step one: identifying which of the millions of possible antibodies will work against molecules that cause disease.